Echo Therapeutics Reports Third Quarter 20...(t to a number of risks and uncertainties...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Echo Therapeutics Reports Third Quarter 2007 Results
Date:11/20/2007
t to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to risks and uncertainties relating to our ability to develop, market and sell pharmaceutical or diagnostic products based on our AzoneTS and CTGM technologies, including AzoneTS-based Durhalieve for corticosteroid responsive dermatoses and the use of our SonoPrep ultrasound-mediated skin permeation technology platform with our CTGM system for the diabetes home use and hospital intensive and critical care markets; the success of our AzoneTS and CTGM business, research, development, and regulatory approval, marketing and distribution plans and strategies; and, our ability to raise sufficient capital in the future to fund our research and development programs, commercialize our product candidates and achieve profitability. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our respective annual reports on Form 10-KSB for the year ended December 31, 2006, our most recent quarterly reports on Form 10-QSB, and our current reports on Form 8-K. Echo Therapeutics, Inc. does not undertake to update these forward- looking statements.
Investor Relations Contacts:
Patrick T. Mooney, M.D., CEO
508-530-0329
10 Forge Parkway
Franklin, MA 02038, USA
Tel: 1+ 877-476-6878
Fax: 1+ 508-553-8760
All rights reserved worldwide.
Echo Therapeutics, Inc.
(Formerly Sontra Medical Corporation)
Consolidated Balance Sheets
As of,
September 30, December 31,
'/>"/>
| SOURCE Echo Therapeutics, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
(Date:9/5/2008)... Mass., Sept. 5 /- Men living in West... with an enlarged prostate,now have the option of ...em. biolitec, Inc. is pleased to announce that a n...g its breakthrough LIFE(TM) (Laser Induced,Flow En...erplasia (BPH),that quickly and gently eliminates ...
(Date:9/5/2008)...ifornia, September 5 /-, - Exchange:...th 2008 a name change to,Fountain Healthy Aging In...l follows the earlier,approval of the name change ...the Company., CEO, Dr Tony Jimenez said a name ch...nd a completely new business plan ", Dr Jimenez w...
(Date:9/5/2008)...and, September 5 /- The 33rd ESMO Con...in Oncology, serves as a,meeting place for medical...,ideas with colleagues from other disciplines., T...iplinary,interaction, a teaching ground, and a pla...y such as cancer research in Europe, the training ...
(Date:9/5/2008)..., Sept. 5 /- Expression Genetics, Inc...TheraPlas(R) cancer drug,has been selected as one ...development available for strategic partnering. Th...ssembled by Windhover Information, a leading,provi...to senior executives,in the pharmaceutical, biotec...
Breaking Biology Technology:Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon 2Immureboost Inc Announces a Change of Name to Fountain Healthy Aging Inc 233rd ESMO Congress in Stockholm, 12-16 September 2008 233rd ESMO Congress in Stockholm, 12-16 September 2008 333rd ESMO Congress in Stockholm, 12-16 September 2008 433rd ESMO Congress in Stockholm, 12-16 September 2008 5Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover 2Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover 3[0] Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon[0] Immureboost Inc Announces a Change of Name to Fountain Healthy Aging Inc[0] 33rd ESMO Congress in Stockholm, 12-16 September 2008[0] Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
...s optimistic that his bill requiring notification ...ure yet this year. , ,Senate Bill 164, co-authore...f Fitzgerald, R-Horicon, would require companies t... notify those people when that data is obtained by... of protecting private information is gaining more...
...red the world pharmaceutical market, the leading t...ers, super blockbusters and mega blockbusters. , ,...ise as key Big Pharma companies increasingly globa...ces and globalized pharmaceutical advertising, thi...and a few select other companies. , ,The reality i...
...s the 51st state to the north. The country brings ...tion technology. , ,In fact, Vancouver, British C... environment, and I was lucky enough to spend the ... some very savvy developers. Over the next few wee...t there. , , Imagis Technologies is a great lesson...
...serv Inc. has unveiled a program of healthcare sav...in financial processing and health-plan administra...ess in 2004, healthcare banking is a set of servic...re accounts for consumers and moving payments betw...inancial institution clients have a great deal of ...
Other Biology Technology:Kanavas thinks personal ID theft bill will pass this year 2Top 20 big pharmas represent majority of world pharma market 2Top 20 big pharmas represent majority of world pharma market 3Imagis emerges from bumpy road 2Imagis emerges from bumpy road 3(Date:9/5/2008)..., Mammalian fatty acid synthase is one of the mos...lls. It is also a promising target for the develop... treatment of metabolic disorders. Now researchers...e of a mammalian fatty acid synthase. Their result... Synthesis of fatty acids is a central cellular p...
(Date:9/4/2008)..., PITTSBURGHDozens of engineers and doctors from ...collaborate on a five-year, $18.5 million project ...ade from biodegradable metals. The devices will be...t,s body and dissolve once they have healed. Natur...devices would reduce the follow-up surgeries and p...
(Date:9/4/2008)..., Let,s raise our water glasses and toast to Am...e of EPA,s highest priorities is ensuring America ...aterborne contaminants. Today, EPA announced the a...iversities, one non-profit, and one research insti...g drinking water contaminants; including the harmf...
(Date:9/4/2008)..., Could a computer model help stabilize the tuna ...hanol fuel without jeopardizing food production? ,...mputer scientists, applied mathematicians, economi...iated with Cornell University,s new Institute for ...a $10 million grant from the National Science Foun...
Breaking Biology News(10 mins):Atomic structure of the mammalian 'fatty acid factory' determined 2Atomic structure of the mammalian 'fatty acid factory' determined 3Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 2Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 3Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 4To your health: EPA announces safe drinking water research 2Cornell gets $10 million NSF grant to establish new sustainability institute 2CrimeCog Technologies Unveils Enhanced JMS Module of E JUSTICE SYSTEMS 28TM 29 3189 1CrimeCog Technologies Unveils Enhanced JMS Module of E JUSTICE SYSTEMS 28TM 29 3189 2CrimeCog Technologies Unveils Enhanced JMS Module of E JUSTICE SYSTEMS 28TM 29 3189 3Customer Communications Group Selected by The Childrens Hospital for Direct Marketing Expertise 18480 1Customer Communications Group Selected by The Childrens Hospital for Direct Marketing Expertise 18480 2Health Care Providers Sue State of California Over Cuts in Medi Cal Payments 18478 1Health Care Providers Sue State of California Over Cuts in Medi Cal Payments 18478 2Health Care Providers Sue State of California Over Cuts in Medi Cal Payments 18478 3Health Care Providers Sue State of California Over Cuts in Medi Cal Payments 18478 4Health Care Providers Sue State of California Over Cuts in Medi Cal Payments 18478 5Consumer Reports 3A Some Drug Prices Can Vary By 24100 or More for the Same Bottle of Pills 18476 1Consumer Reports 3A Some Drug Prices Can Vary By 24100 or More for the Same Bottle of Pills 18476 2Consumer Reports 3A Some Drug Prices Can Vary By 24100 or More for the Same Bottle of Pills 18476 3Consumer Reports 3A Some Drug Prices Can Vary By 24100 or More for the Same Bottle of Pills 18476 4Consumer Reports 3A Some Drug Prices Can Vary By 24100 or More for the Same Bottle of Pills 18476 5[0] Atomic structure of the mammalian 'fatty acid factory' determined[0] Project aims to reduce complications, multiple surgeries with biodegradable implantable devices[0] To your health: EPA announces safe drinking water research[0] Cornell gets $10 million NSF grant to establish new sustainability institute
...eptin, the hormone secreted by fat cells that play...ibed for the first time in a cold-blooded vertebra...t does in humans and other mammals, leptin acts on...one also seems to play a role in the complex signa...d frog, according to Robert Denver, an associate p...
...ack when he was 20 years old in 1965, rock star Pe... get old" into a song, "My Generation" that launch.... , But a unique new study suggests that Townshen..., belief: That the happiest days of people,s lives...finds, both young people and older people think th...
...or nearly four years, a researcher in Washington, ...members respond to treatment for the "silent disea...my colonel and hepatologist, which is a doctor who...ed 90 active-duty servicemembers in her study at t...ch affects the U.S. military at similar rates as t...
...atty acids commonly found in dairy products have s... a researcher at Penn State. The compounds, known ...n promising results in human trials, signaling a n... synthetic drugs. , "The compounds are predomina...and meat, and are formed by bacteria in ruminants ...
Other Biology News:Leptin found to control appetite and limb development in frogs 2Hope I die before I get old? 2Hope I die before I get old? 3Hope I die before I get old? 4Researcher studies, treats military with 'silent disease' 2Researcher studies, treats military with 'silent disease' 3Researcher studies, treats military with 'silent disease' 4Compound in dairy products targets diabetes 2T7Select Biopanning Kit from Novagen
Rabbit polyclonal to LCAT ( Abpromise for all tested applications). entrezGeneID: 3931 SwissProtID: P04180
Rabbit polyclonal to ECSIT ( Abpromise for all tested applications). entrezGeneID: 51295 SwissProtID: Q96HQ7
TaqMan Rodent GAPDH Control Reagents from Applied Biosystems
Biology Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |